Today's Veterinary Practice provides comprehensive information to keep every small animal practitioner up to date on companion animal medicine and surgery as well as practice building and management.
Issue link: http://todaysveterinarypractice.epubxp.com/i/619503
Today's VeTerinary PracTice | January/February 2016 | tvpjournal.com PracTical denTisTry Peer reviewed 94 18. caffesse rG, sweeney Pl, smith Ba. scaling and root planing with and without periodontal fap surgery. J Clin Periodontol 1986; 13:205-210. 19. Holmstrom se, Frost P, eisner er. Periodontal therapy and surgery. in Holmstrom se, Frost P, eisner er (eds): Veterinary Dental Techniques for the Small Animal, 2nd ed. Philadelphia: saunders, 1998, pp 167-213. 20. niemiec Ba. Periodontal therapy. Top Companion Anim Med 2008; 23:81-90. 21. Hamp se, emilson cG. some effects of chlorhexidine on the plaque fora of the beagle dog. J Periodontol Res 1973; 12:28-35. 22. Hull Ps, davies rM. The effect of a chlorhexidine gel on tooth deposits in beagle dogs. J Small Animal Pract 1972; 13:207-212. 23. Maruniak J, clark WB, Walker cB, et al. The effect of 3 mouthrinses on plaque and gingivitis development. J Clin Periodontol 1992; 19:19-23. 24. overholser cd, Meiller TF, dePaola lG, et al. comparative effects of 2 chemotherapeutic mouthrinses on the development of supragingival dental plaque and gingivitis. J Clin Periodontol 1990; 17:575-579. 25. clarke de. clinical and microbiological effects of oral zinc ascorbate gel in cats. J Vet Dent 2001; 18:177-183. 26. logan ei, Finney o, Hefferren JJ. effects of a dental food on plaque accumulation and gingival health in dogs. J Vet Dent 2002; 19:15-18. 27. logan ei, Proctor V, Berg Ml, et al. dietary effect on tooth surface debris and gingival health in cats. Proc Am Vet Dent Forum, 2001, p 377. 28. Brown Wy, McGenity P. effective periodontal disease control using dental hygiene chews. J Vet Dent 2005; 22:16-19. 29. Hennet P, servet e, Venet c. effectiveness of an oral hygiene chew to reduce dental deposits in small breed dogs. J Vet Dent 2006; 23:6-12. 30. Gorrel c, Bierer Tl. long-term effects of a dental hygiene chew on the periodontal health of dogs. J Vet Dent 1999; 16:109-113. 31. Gawor JP, reiter aM, Jodkowska K, et al. infuence of diet on oral health in cats and dogs. J Nutr 2006; 136:2021s-2023s. 32. Harvey ce, shofer Fs, laster l. correlation of diet, other chewing activities, and periodontal disease in north american client-owned dogs. J Vet Dent 1996; 13:101-105. 33. niemiec Ba. Host modulation therapies. in niemiec Ba (ed): Veterinary Periodontology. ames, ia: Wiley Blackwell, 2013, pp 299-304. 34. lang nP, Mombelli a, attstrom r. dental plaque and calculus. in lindhe J, Karring T, lang nP (eds): Clinical Periodontology and Implant Dentistry, 3rd ed. denmark: Munksgaard, 2002, pp 102-134. 35. Thoden Van Velzen sK, abraham-inpijin l, Modrer Wdr. Plaque and systemic disease: a reappraisal of the focal infection concept. J Clin Periodontol 1984; 11:209-220. 36. s cannapieco Fa. Periodontal infammation: From gingivitis to systemic disease? Compend Contin Educ Pract Vet 2004; 25 (suppl 1):16-25. 37. nisengard rJ, Kinder Haake s, newman MG, Miyasaki KT. Microbial interactions with the host in periodontal diseases. Carranza's Clinical Periodontology. st. louis: WB saunders, 2006, pp 228-250. 38. nassar ca, nassar Po, nassar PM, spolidorio lc. selective cyclooxygenase-2 inhibition prevents bone resorption. Braz Oral Res 2005; 19:36-40. 39. Queiroz-Junior cM, Pacheco cM, Maltos Kl, et al. role of systemic and local administration of selective inhibitors of cyclo-oxygenase 1 and 2 in an experimental model of periodontal disease in rats. J Periodontal Res 2009; 44:153-160. 40. emingil G, atilla G, s orsa T, et al. effectiveness of adjunctive low-dose doxycycline therapy on clinical parameters and gingival crevicular fuid laminin-5 gamma2 chain levels in chronic periodontitis. J Periodontol 2004; 75:1387-1396. 41. Gürkan a, cinarcik s, Hüseyinov a. adjunctive subantimicrobial dose doxycycline: effect on clinical parameters and gingival crevicular fuid transforming growth factor-beta levels in severe, generalized chronic periodontitis. J Clin Periodontol 2005; 32:244-253. 42. Gürkan a, emingil G, cinarcik s, Berdeli a. Post-treatment effects of subantimicrobial dose doxycycline on clinical parameters and gingival crevicular fuid transforming growth factor-beta1 in severe, generalized chronic periodontitis. Int J Dent Hyg 2008; 6:84-92. 43. serhan cn, Gotlinger K, Hong s, arita M. resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis. Prostaglandins Other Lipid Mediat 2004; 73:155-172. 44. Hasturk H, Kantarci a, ohira T, et al. rve1 protects from local infammation and osteoclast-mediated bone destruction in periodontitis. FASEB J 2006; 20:401-403. 45. arita M, yoshida M, Hong s. resolvin e1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Proc Natl Acad Sci USA 2005; 102:7671-7676. 46. arita M, Bianchini F, aliberti J, et al. stereochemical assignment, antiinfammatory properties, and receptor for the omega-3 lipid mediator resolvin e1. J Exp Med 2005; 201:713-722. 47. arita M, ohira T, sun yP, et al. resolvin e1 selectively interacts with leukotriene B4 receptor BlT1 and chemr23 to regulate infammation. J Immunol 2007; 178:3912-3917. 48. arita M, clish cB, serhan cn. The contributions of aspirin and microbial oxygenase to the biosynthesis of anti- infammatory resolvins: novel oxygenase products from omega-3 polyunsaturated fatty acids. Biochem Biophys Res Commun 2005; 338:149-157. 49. s erhan cn, savill J. resolution of infammation: The beginning programs the end. Nat Immunol 2005; 6:1191- 1197. 50. Bannenberg Gl, chiang n, ariel a, et al. Molecular circuits of resolution: Formation and actions of resolvins and protectins. J Immunol 2005; 174:4345-4355. 51. schwab JM, chiang n, arita M, serhan cn. resolvin e1 and protectin d1 activate infammation-resolution programmes. Nature 2007; 447:869-874. 52. Hasturk H, Kantarci a, Goguet-surmenian e, et al. resolvin e1 regulates infammation at the cellular and tissue level and restores tissue homeostasis in vivo. J Immunol 2007; 179:7021-7029. 53. Van dyke Te. The management of infammation in periodontal disease. J Periodontol 2008; 79 (suppl 8):1601- 1608. 54. Gurgel Bc, duarte PM, nociti FH Jr, et al. impact of an anti- infammatory therapy and its withdrawal on the progression of experimental periodontitis in rats. J Periodontol 2004; 75:1613-1618. 55. oliveira TM, sakai VT, Machado Ma, et al. coX-2 inhibition decreases VeGF expression and alveolar bone loss during the progression of experimental periodontitis in rats. J Periodontol 2008; 79:1062-1069. 56. Buduneli n, Buduneli e, cetin eo, et al. clinical fndings and gingival crevicular fuid prostaglandin e2 and interleukin-1- beta levels following initial periodontal treatment and short- term meloxicam administration. Exp Opin Pharmacother 2010; 11:1805-1812. 57. Holzhausen M, rossa Júnior c, Marcantonio Júnior e, et al. effect of selective cyclooxygenase-2 inhibition on the development of ligature-induced periodontitis in rats. J Periodontol 2002; 73:1030-1036. 58. Holzhausen M, spolidorio dM, Muscará Mn, et al. Protective effects of etoricoxib, a selective inhibitor of cyclooxygenase-2, in experimental periodontitis in rats. J Periodontal Res 2005; 40:208-211. 59. Bezerra MM, de lima V, alencar VB, et al. selective cyclooxygenase-2 inhibition prevents alveolar bone loss in experimental periodontitis in rats. J Periodontol 2000; 71:1009- 1014. 60. Paquette dW, Fiorellini JP, Martuscelli G, et al. enantiospecifc inhibition of ligature-induced periodontitis in beagles with